rxstat › Shortages › Ticagrelor

Ticagrelor shortage status

No current shortage

Source: Health Canada shortage reports · Updated Oct 27, 2026

Ticagrelor has no current shortage reported in Canada. It has been in shortage before; the history is below.

An antiplatelet blood thinner used to prevent blood clots after a heart attack or in heart disease.

Products affected
0 / 4
Reports on file
23

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved
APO-TICAGRELOR
90MG · TABLET · APOTEX INC
DIN 02482630 · ended Jul 23, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Sep 30, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
60MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492571 · ended Sep 21, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-TICAGRELOR
60MG · TABLET · APOTEX INC
DIN 02482622 · ended Sep 17, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Mar 9, 2026 · Disruption of the manufacture of the drug.
Avoided
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Nov 25, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
60MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492571 · ended Nov 28, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
60MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492571 · ended Nov 28, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Oct 31, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Sep 5, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-TICAGRELOR
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02492598 · ended Apr 11, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-TICAGRELOR
90MG · TABLET · APOTEX INC
DIN 02482630 · ended Jan 9, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 23 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Ticagrelor. Health Canada has 23 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Ticagrelor is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AC).

Recent changes

Common questions

What is Ticagrelor used for?

An antiplatelet blood thinner used to prevent blood clots after a heart attack or in heart disease.

When will Ticagrelor be back in stock in Canada?

Ticagrelor has no active shortage; supply is normal per Health Canada reports.

Why is Ticagrelor in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (antithrombotic agents)

Nadroparin (Fraxiparine) Widespread shortage 7 of 8 reported products affected Clopidogrel (Plavix) Partial shortage 1 of 18 reported products affected Dabigatran Etexilate (Pradaxa) Partial shortage 2 of 6 reported products affected Edoxaban (Lixiana) Partial shortage 2 of 9 reported products affected · est. return Jan 22, 2027 Rivaroxaban (Xarelto) Partial shortage 1 of 18 reported products affected · est. return Nov 30, 2026 Ticlopidine Partial shortage 1 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.